National Pharmaceutical Council (NPC)

npc400x150.jpgNPC was established in 1953 and is supported by the nation’s major research-based pharmaceutical companies. While NPC’s overarching mission remains to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation, in 2007 NPC announced a new strategic focus on evidence-based medicine (EBM) for health care decision-making.

The Patient-Centered Outcomes Research Institute Research Guide

NPC’s Patient-Centered Outcomes Research Institute Resource Guide was created to foster better understanding of the role of the PCORI Board of Governors and of issues related to comparative effectiveness research (CER). This guide provides specifics concerning PCORI’s implementation, biographies of the new PCORI Board members, a history of CER in the United States, and other relevant resources.

National Institute for Health and Clinical Excellence (NICE): How Does It Work? (Full study)

This four-part study, commissioned by the National Pharmaceutical Council, examines the U.K.’s National Institute for Health and Clinical Excellence (NICE) and its operations, as well as the implications for comparative effectiveness reviews in the United States. NICE is the organization that provides guidance to the U.K.’s National Health Service on the clinical and economic effects of various medical treatments.

National Institute for Health and Clinical Excellence (NICE): How Does It Work? (Executive summary)

This study, authored by Dr. Michael Drummond and his colleagues at the London School of Economics, provides an overview of the U.K.’s National Institute for Health and Clinical Excellence (NICE) and offers conclusions about what the U.K.'s experiences mean for establishing a more formalized system for collecting comparative effectiveness information in the U.S.